摘要
目的研究术后化疗对Ⅰ期肺腺癌长期生存的影响。方法收集1995年1月~2005年1月手术切除Ⅰ期(Ⅰa+Ⅰb)肺腺癌427例,比较术后化疗组与单纯手术组的治疗效果。结果Ia期1、3、5、10年生存率,术后化疗组为100.00%、92.34%、86.17%、74.82%。单纯手术组为9663%、88.11%、79.52%、65.85%。Ⅰb期1、3、5、10年生存率,术后化疗组为96馏4%、77.99%、69.56%、64.36%。单纯手术组为85.65%、67.11%、59.56%、53.06%。Ⅰa、Ⅰb期术后化疗组与单纯手术组1年生存率比较差异均有统计学意义(P〈0.05,P〈0.01)。结论Ⅰa和Ⅰb术后化疗均比单纯手术预后好;Ⅰ期肺腺癌要取得较好的治疗效果,手术加术后化疗模式不可缺少。
Objective Observe the effect of operation plus post-operative chemotherapy for long term results of stage I lung adenocarcinoma. Methods From January 1994 to January 2005, 427 patients with stage I lung adenocarcinoma underwent surgical resection therapy.The comparison of long-term survival rates was made between post-chemotherapy and surgical resection alone.Results The analyses disclosed that the stage Ⅰ a 1, 3, 5 and 10-year survival rate of post-chemotherapy was 100.00%, 92.34%, 86.17% and 74.82%, respectively, while in surgical resection alone was 96.63%, 88.11%, 79.52% and 65.85%, respectively The stage Ⅰ b 1, 3, 5 and 10-year survival rate of post-chemotherapy was 96.84%, 77.99%, 69.56% and 64.36%, respectively, while in surgical resection alone was 85.65%, 67.11%, 59.56%and 53.06%,respectively.There was statistically significant difference between 1 year survival rate of stage la patients with post- chemotherapy and those with surgical resection alone (P〈0.05)) 1 year survival rate of stage I b patients with post-chemotherapy and those with surgical resection alone(P〈0.01).Conclusion The operation plus post-operative chemotherapy is better than surgical resection alone in stage 1 a and I b.Surgical plus post-operative chemotherapy mode is indispensable for better prognosis of stage Ia and lb lung adenocarcinoma.
出处
《结核病与胸部肿瘤》
2009年第3期211-213,共3页
Tuberculosis and Thoracic Tumor
关键词
肺肿瘤
外科手术
药物疗法
联合
Lung neoplasms Surgical procedures, operative Drug therapy, combination